D

DURECT Corp
D

DRRX

0.70830
USD
0.04
(6.24%)
مغلق
حجم التداول
353
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
21,987,460
أصول ذات صلة
A
ALDX
0.30000
(7.52%)
4.29000 USD
A
AQST
0.04500
(1.22%)
3.72000 USD
A
AXSM
1.415
(1.36%)
105.335 USD
B
BHC
-0.14000
(-1.97%)
6.98000 USD
B
BNTC
0.290
(2.26%)
13.150 USD
CAH
CAH
3.340
(2.06%)
165.200 USD
المزيد
الأخبار المقالات

العنوان: DURECT Corp

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entitiesand proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.